Market Alert: ASX200 at Critical Support – Reversal or Further Fall?

Nutritional Growth Solutions Expands U.S. Retail Presence with Wakefern and Walmart

Mar 04, 2025

Nutritional Growth Solutions (ASX: NGS) is a U.S.-based health, nutrition, and wellness company specializing in clinically tested nutritional supplements for children. With over 20 years of paediatric nutrition research, NGS focuses on the underserved market of children aged 3-12. The company’s flagship brand, Healthy Heights®, is expanding its U.S. retail presence, securing distribution in ~300 Wakefern stores and increasing Walmart’s product range to 972 locations. The expansion is expected to generate annualized sales of approximately USD 750,000 (~AUD 1.2 million). Wakefern, a major Northeast U.S. grocery retailer, provides significant market exposure, while Walmart’s growing distribution reflects increasing consumer demand. NGS differentiates itself with scientifically backed products designed to support healthy growth and development. By strategically expanding its retail footprint and leveraging clinically tested formulations, NGS aims to capture a significant share of the growing children’s nutrition market.

 

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com